STEPHANI BRISBIN: Open Payments
NPI 1487151106 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 14 payments from 9 companies in 2025. Trend: 2023 $77 · 2024 $283 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $66 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Lundbeck LLC | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: TRELEGY ELLIPTA, QULIPTA, VRAYLAR, REXULTI, ROTATEQ, GEMTESA, NURTEC ODT, BREZTRI.
Industry payments across OK — which companies pay providers there.
